Obayashi Corp
TSE:1802
Obayashi Corp
TSE:1802
Price:
2 050
JPY
-1.13%
Market Cap:
1.5T
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Obayashi Corp
2050
-23.5 (-1.13%)
| 52 Week Range |
1 210.5
2 163
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Obayashi Corp
Balance Sheet
Balance Sheet Decomposition
Obayashi Corp
Obayashi Corp
| Current Assets | 1.7T |
| Cash & Short-Term Investments | 279.5B |
| Receivables | 1.2T |
| Other Current Assets | 214.2B |
| Non-Current Assets | 1.3T |
| Long-Term Investments | 351.1B |
| PP&E | 751.5B |
| Intangibles | 41.6B |
| Other Non-Current Assets | 145B |
| Current Liabilities | 1.4T |
| Accounts Payable | 747.4B |
| Short-Term Debt | 25B |
| Other Current Liabilities | 621.6B |
| Non-Current Liabilities | 437.3B |
| Long-Term Debt | 269.5B |
| Other Non-Current Liabilities | 167.8B |
Balance Sheet
Obayashi Corp
Obayashi Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
164 309
|
164 829
|
194 585
|
190 055
|
168 698
|
315 027
|
258 549
|
265 042
|
419 405
|
339 188
|
|
| Cash Equivalents |
164 309
|
164 829
|
194 585
|
190 055
|
168 698
|
315 027
|
258 549
|
265 042
|
419 405
|
339 188
|
|
| Short-Term Investments |
2 835
|
2 606
|
2 519
|
4 615
|
6 980
|
7 103
|
4 401
|
5 988
|
7 285
|
8 430
|
|
| Total Receivables |
792 278
|
794 791
|
819 303
|
855 165
|
963 395
|
861 381
|
830 154
|
992 677
|
952 847
|
1 197 284
|
|
| Accounts Receivables |
696 589
|
723 732
|
741 294
|
775 742
|
870 841
|
786 256
|
765 653
|
914 244
|
853 981
|
1 069 961
|
|
| Other Receivables |
95 689
|
71 059
|
78 009
|
79 423
|
92 554
|
75 125
|
64 501
|
78 433
|
98 866
|
127 323
|
|
| Inventory |
126 969
|
131 137
|
131 098
|
139 456
|
123 583
|
127 493
|
150 485
|
110 868
|
100 437
|
111 522
|
|
| Other Current Assets |
34 755
|
35 405
|
34 140
|
18 700
|
20 210
|
22 753
|
25 816
|
20 942
|
25 577
|
32 713
|
|
| Total Current Assets |
1 121 146
|
1 128 768
|
1 181 645
|
1 207 991
|
1 282 866
|
1 333 757
|
1 269 405
|
1 395 517
|
1 505 551
|
1 689 137
|
|
| PP&E Net |
408 848
|
441 604
|
459 597
|
526 270
|
544 558
|
572 190
|
609 256
|
623 306
|
692 545
|
735 914
|
|
| Intangible Assets |
6 369
|
6 404
|
6 558
|
5 038
|
4 997
|
6 367
|
6 437
|
8 648
|
17 932
|
36 465
|
|
| Note Receivable |
2 181
|
0
|
2 024
|
876
|
1 767
|
2 109
|
1 769
|
2 096
|
1 312
|
2 637
|
|
| Long-Term Investments |
415 541
|
342 021
|
346 245
|
372 308
|
360 627
|
290 719
|
340 079
|
337 976
|
306 570
|
422 583
|
|
| Other Long-Term Assets |
42 108
|
30 940
|
19 927
|
16 544
|
19 697
|
25 155
|
45 682
|
54 542
|
86 019
|
130 311
|
|
| Total Assets |
1 996 193
N/A
|
1 951 907
-2%
|
2 015 996
+3%
|
2 129 027
+6%
|
2 214 512
+4%
|
2 230 297
+1%
|
2 272 628
+2%
|
2 422 085
+7%
|
2 609 929
+8%
|
3 017 047
+16%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
627 024
|
609 230
|
635 697
|
658 482
|
671 137
|
655 839
|
572 669
|
629 717
|
672 254
|
820 867
|
|
| Short-Term Debt |
117 033
|
97 130
|
72 789
|
0
|
40 834
|
38 210
|
38 210
|
43 206
|
46 405
|
52 795
|
|
| Current Portion of Long-Term Debt |
59 045
|
70 271
|
48 626
|
108 333
|
38 061
|
25 083
|
24 609
|
33 995
|
50 801
|
35 704
|
|
| Other Current Liabilities |
255 670
|
296 569
|
321 572
|
352 020
|
345 152
|
371 038
|
357 437
|
421 684
|
456 974
|
524 151
|
|
| Total Current Liabilities |
1 058 772
|
1 073 200
|
1 078 684
|
1 118 835
|
1 095 184
|
1 090 170
|
992 925
|
1 128 602
|
1 226 434
|
1 433 517
|
|
| Long-Term Debt |
234 972
|
179 146
|
152 154
|
168 653
|
193 623
|
186 539
|
204 169
|
203 671
|
247 156
|
244 404
|
|
| Deferred Income Tax |
77 518
|
63 143
|
68 047
|
54 258
|
49 620
|
24 229
|
39 873
|
28 667
|
22 474
|
64 982
|
|
| Minority Interest |
41 812
|
45 559
|
49 916
|
26 688
|
29 204
|
32 606
|
30 970
|
33 222
|
38 772
|
43 180
|
|
| Other Liabilities |
75 448
|
74 760
|
73 035
|
75 756
|
77 936
|
78 861
|
73 682
|
72 232
|
77 984
|
79 334
|
|
| Total Liabilities |
1 488 522
N/A
|
1 435 808
-4%
|
1 421 836
-1%
|
1 444 190
+2%
|
1 445 567
+0%
|
1 412 405
-2%
|
1 341 619
-5%
|
1 466 394
+9%
|
1 612 820
+10%
|
1 865 417
+16%
|
|
| Equity | |||||||||||
| Common Stock |
57 752
|
57 752
|
57 752
|
57 752
|
57 752
|
57 752
|
57 752
|
57 752
|
57 752
|
57 752
|
|
| Retained Earnings |
199 296
|
255 750
|
334 957
|
404 840
|
498 195
|
587 012
|
661 512
|
677 559
|
728 087
|
773 841
|
|
| Additional Paid In Capital |
41 750
|
41 752
|
41 752
|
43 135
|
42 540
|
42 825
|
42 641
|
42 641
|
41 962
|
42 002
|
|
| Unrealized Security Profit/Loss |
204 941
|
0
|
160 681
|
178 677
|
169 329
|
123 851
|
158 921
|
159 287
|
141 684
|
228 400
|
|
| Treasury Stock |
1 608
|
0
|
1 964
|
1 929
|
2 132
|
2 121
|
2 090
|
2 808
|
2 754
|
2 711
|
|
| Other Equity |
5 540
|
1 538
|
982
|
2 362
|
3 261
|
8 573
|
12 273
|
21 260
|
30 378
|
52 346
|
|
| Total Equity |
507 671
N/A
|
516 099
+2%
|
594 160
+15%
|
684 837
+15%
|
768 945
+12%
|
817 892
+6%
|
931 009
+14%
|
955 691
+3%
|
997 109
+4%
|
1 151 630
+15%
|
|
| Total Liabilities & Equity |
1 996 193
N/A
|
1 951 907
-2%
|
2 015 996
+3%
|
2 129 027
+6%
|
2 214 512
+4%
|
2 230 297
+1%
|
2 272 628
+2%
|
2 422 085
+7%
|
2 609 929
+8%
|
3 017 047
+16%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
718
|
718
|
718
|
718
|
718
|
718
|
718
|
717
|
717
|
717
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
